Assyro AI

Orange Book product · Generic (ANDA)

ESCITALOPRAM OXALATE

ESCITALOPRAM OXALATE

Generic (ANDA)ANDA 215177TE ABRX ASCENT PHARMS INC
View ESCITALOPRAM OXALATE familyOpen on FDA Orange Book

At a glance

Jul 15, 2025

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 15, 2025

    11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ESCITALOPRAM OXALATE

Strength

EQ 5MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 215177

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ESCITALOPRAM OXALATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo